-
Loading metrics
Open Access
Peer-reviewed
Research Article
Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria
-
Ruth D. Ellis,
Current address: Aeras Global TB Vaccine Foundation, Rockville, Maryland, United States of America
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Yimin Wu ,
* E-mail: yiwu@niaid.nih.gov
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Laura B. Martin,
Current address: Novartis Vaccines Institute for Global Health, Siena, Italy
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Donna Shaffer,
Affiliation Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯ -
Kazutoyo Miura,
Affiliation Biostatistics Research Branch, NIAID/NIH, Rockville, Maryland, United States of America
⨯ -
Joan Aebig,
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Andrew Orcutt,
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Kelly Rausch,
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Daming Zhu,
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Anders Mogensen,
Current address: LEO Pharma, API Manufacturing, Ballerup, Denmark
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Michael P. Fay,
Affiliation Biostatistics Research Branch, NIAID/NIH, Rockville, Maryland, United States of America
⨯ -
David L. Narum,
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Carole Long,
Affiliation Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, United States of America
⨯ -
Louis Miller,
Affiliation Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), Rockville, Maryland, United States of America
⨯ -
Anna P. Durbin
Affiliation Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯
Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria
- Ruth D. Ellis,
- Yimin Wu,
- Laura B. Martin,
- Donna Shaffer,
- Kazutoyo Miura,
- Joan Aebig,
- Andrew Orcutt,
- Kelly Rausch,
- Daming Zhu,
- Anders Mogensen
- Published: October 4, 2012
- https://doi.org/10.1371/journal.pone.0046094